MGAT5
MGAT5 (alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase, also known as GNT-V or MGAT5A) is a Golgi glycosyltransferase that adds beta-1,6-N-acetylglucosamine to N-linked oligosaccharides on newly synthesised glycoproteins. It helps regulate glycoprotein oligosaccharide biosynthesis. Browse Assay Genie's current range of MGAT5 research reagents below, or read on for the biology behind the target.
MGAT5 catalyses the addition of beta-1,6-N-acetylglucosamine to the alpha-linked mannose of biantennary N-linked oligosaccharides present on newly synthesised glycoproteins. It is described as one of the most important enzymes in the regulation of glycoprotein oligosaccharide biosynthesis. Because changes to the oligosaccharides on cell surface glycoproteins alter the adhesive and migratory behaviour of a cell, the activity of this enzyme has direct consequences for cell behaviour.
The MGAT5 protein belongs to the glycosyltransferase 18 family and is classified as EC 2.4.1.155. UniProt lists its subcellular locations as the Golgi apparatus membrane and the secreted fraction. Beyond its role in glycan processing, UniProt annotates a function in promoting the proliferation of umbilical vein endothelial cells and angiogenesis, at least in part by promoting release of the growth factor FGF2 from the extracellular matrix.
The MGAT5 gene is classed by HGNC within the mannosyl-glycoprotein N-acetylglucosaminyltransferases and also among the microRNA protein coding host genes. Its previous name was mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase. Increased enzyme activity has been correlated with the progression of invasive malignancies, which makes MGAT5 a frequent subject in studies of glycosylation and cancer biology. Orthologues are named Mgat5 in both mouse and rat.
MGAT5 adds beta-1,6-N-acetylglucosamine to N-linked oligosaccharides, making it a key enzyme for studying how glycoprotein oligosaccharide biosynthesis is regulated.
Increased MGAT5 activity has been correlated with the progression of invasive malignancies, so it is studied in relation to tumour invasion.
Changes to oligosaccharides on cell surface glycoproteins alter adhesive and migratory behaviour, and MGAT5 is one of the enzymes shaping them.
MGAT5 promotes endothelial cell proliferation and angiogenesis, at least in part by promoting FGF2 release from the extracellular matrix.
MGAT5 is a Golgi enzyme that adds beta-1,6-N-acetylglucosamine to the alpha-linked mannose of biantennary N-linked oligosaccharides on newly synthesised glycoproteins. It also promotes endothelial cell proliferation and angiogenesis, partly by promoting FGF2 release from the extracellular matrix.
MGAT5 is also called GNT-V and MGAT5A. Its full name is alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase, and UniProt lists it as the A form of that name. An earlier HGNC name was mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase.
Mouse and rat both have an orthologue named Mgat5; check the datasheet of any product for its validated reactivity. Increased MGAT5 enzyme activity has been correlated with the progression of invasive malignancies, according to the NCBI Gene summary.
Other mannosyl-glycoprotein N-acetylglucosaminyltransferases involved in N-glycan processing.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q09328; product specifications from Assay Genie datasheets.